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ABSTRACT 
Objective: The objective of the present study was to formulate and evaluate liposomes loaded with isoniazid.  
Methods: Liposome of isoniazid was made by thin layer film hydration method. L-α-phosphatidylcholine and cholesterol were used to make 
multiamellar vesicles. Six batches of liposomes were prepared based on the different weight ratio of L-α-phosphatidylcholine and cholesterol. 
Differential scanning calorimetry (DSC) study conducted to study in any incompatibility.  
Results: The prepared liposomes were evaluated by particle size analysis, entrapment efficiency, release study and stability study. Particle sizes 
were determined from the scanning electron microscopy (SEM) photographs. When particle frequencies were plotted against particle diameter in 
the histogram, it showed that F1 batch had a skewed distribution towards smaller liposomes while F6 shows a proper bell-shaped curve with a 
mean at 225 µm. The percentage entrapment efficiency was found to be 8.99 ± 0.15 to 4.19 ± 0.12 % respectively. From the release profile, it was 
seen that F1 batch was fastest and F6 was slowest to release the drug. The satisfactory batch F1 was packed in Eppendorf tube and stored at 4 °C 
temperature for one month. At the end of one month, the samples were analyzed for their physical properties, drug entrapment and in vitro release 
profile. The percentage release was found to be 96.5 ± 3.2 after 4 h.  
Conclusion: The F1 batch showed most promising results compared to other. No significant change was found during one month’s stability study of 
final batch (F1). 
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Liposome has become an essential therapeutic tool most notably in 
drug delivery and targeting. Structurally, liposomes are concentric 
bilayered vesicles in which an aqueous volume is enclosed by a 
membranous lipid bilayer mainly composed of natural or synthetic 
phospholipids [1]. Liposomes are formed when thin lipid films or 
lipid cakes are hydrated and stacks of lipid crystalline bilayers 
become fluid and swell. The hydrated lipid sheets get detached 
during agitation and self-close to form large, multiamellar vesicles 
(MLVs), which prevent interaction of water with the hydrocarbon 
core of the bilayer at the edges. Once these MLVs are formed, a 
change in vesicle shape and morphology may require energy input in 
the form of sonic energy and/or mechanical energy. The former 
produce small unilamellar vesicles (SUVs) while the latter usually 
produces large unilamellar vesicles. Liposomal drug delivery system 
is very useful for delivery of anticancer, antifungal, antibacterial, 
antiparasites, ocular and antiviral drugs [2-4].  
Phospholipids such as phosphatidylcholine (PC) and cholesterol 
were selected for the formation of liposomes into which the drug 
was incorporated. Phospholipids are amphipathic molecules as they 
have a hydrophobic tail and a hydrophilic or polar head. Cholesterol 
acts as a ‘fluidity buffer’ since below the phase transition it tends to 
make membrane less ordered while above transition it tends to 
make membrane more ordered thus suppressing the tilts and shifts 
in membrane structure specifically at the phase transition. Though 
cholesterol itself does not form bilayers, but it can be incorporated 
into phospholipid membrane in high concentration in the different 
molar ratio of cholesterol to PC [5]. 
Tuberculosis is an infectious bacterial disease, which most commonly 
affects the lungs. Isoniazid, also known as isonicotinic acid hydrazide 
(INH), is the first-line medication for tuberculosis and it is most widely 
used for treatment and prevention of tuberculosis [6]. 
The purpose of the present study was to design, formulate and evaluate 
the liposomes containing Isoniazid by in vitro methods. The liposomal 
formulations are designed for intramuscular administration for a 
sustained release action and at the same time automatic absorption of 
the delivery system, since all the components are biodegradable. 
MATERIALS AND METHODS 
Materials 
Isoniazid, L-α-phosphatidylcholine (soya lecithin), cholesterol were 
purchased from yarrow Chem., Mumbai. Chloroform was purchased 
from Merck India. All the chemicals and reagents were used were of 
analytical grade. 
Preparation of liposome by thin layer film hydration method  
A solution of L-α-phosphatidylcholine and cholesterol in a specified 
weight ratio (F1=1:1, F2=2:1, F3=3:1, F4=4:1, F5=5:1 and F6=6:1) 
was dissolved in 5 ml chloroform. The chloroform solution was 
placed inside a 250 ml round bottom flask and rotated in the same 
direction. The flask was kept in a thermostatic water bath, and 
rotated while maintaining a temperature of 30 ° to 35 ° C. Rotation 
was continued till all the chloroform evaporates from the solution 
and a thin lipid film was deposited on the inner wall of the flask. An 
aqueous solution of isoniazid (5 ml containing 100 mg drug) was 
added to the flask and was rotated with the same speed as before for 
30 min or until all the lipid was removed from the wall of the flask. 
The suspension was allowed to stand for a period of 15 min on 
water bath at 30 °C temperature for complete hydration.  
Then, the suspension was taken into a bath type sonicator and 
sonicated for 30 min. Separation of non-entrapped drug was carried 
out by centrifugation at 3700 rpm for 40 min. The liposomal 
suspension was cooled by placing the test tubes in ice-cold water 
prior to centrifugation. Then liposome pellet was collected and re-
suspended in distilled water [7, 13, 15].  
Study of physical interaction between drug and excipients  
Differential Scanning Calorimetry (DSC) thermograms were taken by 
scanning the samples of (i) pure isoniazid, (ii) excipients containing 
(lecithin, cholesterol) and (iii) the formulation (F1 and F6) using 
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DSC (Pyris Diamond TG/DTA, PerkinElmer, SINGAPORE) in nitrogen 
atmosphere (150 ml/min). Platinum crucibles were used with alpha 
alumina powder as reference [8, 16]. 
Particle size analysis  
One drop of the Liposomal formulation was homogeneously spread 
onto a glass slide and left to dry overnight. After platinum coating 
the sample with a Polaron E5100 sputter coater (Polaron, England), 
the samples were observed under a Philips 505 scanning electron 
microscope at an accelerating voltage of 20 kV. Photographs were 
taken at 70, 100, 200, and 300 magnifications wherever necessary. 
Particle diameters were taken from the photographs by taking the 
scale shown in each photograph [9]. 
Drug entrapment studies  
To aliquots of liposome sample (0.5 ml), 5 ml of 10% sodium lauryl 
sulphate (SLS) was added and the volume was made up to 50 ml. The 
sample was warmed on a water bath at 70 °C for 30 min. Similarly, a 
blank liposome (without drug) suspension (0.5 ml), 5 ml of 10% SLS 
were taken in 50 ml volumetric flask and the volume was made up 
with distilled water. The blank was warmed on a water bath at 70 °C 
for 30 min. The absorbance of the test solution was taken in UV-
spectrophotometer at 263 nm against the blank solution [10].  
Percentage of entrapment efficiency  
It was determined by using the ratio of entrapped drug (mg) to the total 
drug (mg), which may be expressed by the following formula [10, 14].  
 
In vitro drug release study from liposomes 
Concentrated liposomal suspension, 0.5 ml was taken in a test tube 
of opening diameter of 20 mm. The open end was covered with a 
semi-permeable dialysis membrane (Himedia Laboratories Pvt. Ltd.) 
and tied with a thread. The test tube was inverted and placed over 
the surface of 100 ml water present in a 250 ml beaker in such a way 
that the membrane just touched the water surface. The test tube was 
secured by a clamp fixed with a stand. The water in the beaker was 
stirred with a magnetic stirrer so that no vortex could form in the 
beaker. The temperature was maintained at 37 °C. The drug released 
from the liposomes permeates across the membrane and enters into 
the receptor chamber medium. Samples of 2 ml were taken out from 
the receptor chamber medium, suitably diluted, and the absorbances 
were taken by UV-spectrophotometer at 263 nm against a blank of 
fresh medium. At the same time, 2 ml of fresh medium was added to 
the beaker to keep the volume of the medium constant in the beaker 
[11, 17].  
Stability test  
The behaviour of the liposome to retain the drug was studied by 
storing the liposome at 4 to 8 ° C (refrigerator RF) for a period of 1 
mo. The liposomal preparations were kept in sealed vials [11, 12]. 
RESULTS AND DISCUSSION 
Physical interaction between drug and excipients 
The pre-formulation study of drug-excipient interaction was carried 
out by DSC, which showed no interactions of the drugs and 
excipients. The melting point of the pure Isoniazid was found from 
the peak of DSC thermogram at 172.81 °C (fig. 1a). The results are 
shown in fig. 1a to 1d. Phosphatidylcholine is a semisolid material 
that showed a wider peak at 136.61 °C (fig. 1b). Cholesterol 
exhibited a much sharper peak at 147.29 °C (fig. 1c). Finally, the 
liposome formulation F1 showed a melting point at 112.41 °C (fig. 
1d) that is much lower than all the individual pure components. The 
peak is bifurcated also. Thus DSC thermogram showed some 
interaction with the three components. 
 
 
Fig. 1a: DSC curve of pure Isoniazid 
 
 
Fig. 1b: DSC curve of phosphatidylcholine 
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Fig. 1c: DSC curve of cholesterol 
 
 
Fig. 1d: DSC curve of F1 
 
  
Fig. 2: SEM of F1 
 
  
Fig. 3: SEM of F 6 
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Particle size analysis  
Particle sizes were determined from the SEM photographs. Both F1 
and F6, the two extreme formulations, were observed under SEM 
and the size of the liposomal vesicles was measured at different 
locations on photographs. 
When particle frequencies were plotted against diameter the 
histogram in fig. 4 showed that F1 had a skewed distribution 
towards smaller liposome’s while F6 shows a proper bell-shaped 
curve with a mean at 270 µm. The % entrapment efficiency of 
different batches is shown on the table 1. 
 
 
Fig. 4: Particle size distribution of F1 and F6 batches, *each value is represented as a mean±SD, n=3 
 
Table 1: Drug entrapment and % entrapment efficiency of liposome formulations 
Formulation batches Drug entrapment (mg of drug/ml of liposomal suspension) % entrapment efficiency 
F1 17.98 ± 0.99 8.99 ± 0.15 
F2 16.49 ± 0.51 8.25 ± 0.19 
F3 13.71 ± 0.59 6.85 ± 0.15 
F4 13.57 ± 0.32 6.79 ± 0.22 
F5 9.52 ± 0.40 4.76 ± 0.10 
F6 8.39 ± 0.37 4.19 ± 0.12 
*Each value is represented as a mean±SD, n=3 
 
 
Fig. 5: Drug release (%) from all the liposomal formulations, *each value is represented as a mean±SD, n=3 
 
The drug release pattern of all liposome formulations containing 
isoniazid was shown fig. 5. From the graph, it was seen that the drug 
release of F1 batch was fastest (97.3 ± 6.2 at 240 min) and F6 was 
slowest (20.40 ± 2.9 % at 240 min). 
Many physicochemical parameters are investigated as major reasons 
for liposome instability. Oxidation and hydrolysis are the main 
reasons for chemical instability, as they occur in phospholipid 
unsaturated chains. Stored at low temperatures and light 
preservation can avoid such reactions. Proper entrapment, pH 
adjustment, temperature, ionic interaction and application of 
cholesterol in bilayer structure can successfully cause liposome 
stability. In this study, liposomes were stored at low temperature 
and far from light by application of cholesterol in the formulation. 
The efficacy of the cholesterol in various formulations as an 
indicator of stability was proved [18]. 
The satisfactory formulation (F1) was packed in the tube and stored 
at 4-8 °C temperature for one month. At the end of one month, the 
samples were analyzed for their physical property, drug entrapment 
and in vitro release study. The % entrapment efficiency was found 
8.97 ± 0.14 and % release was found 96.5 ± 3.2. So there was no 
significant change was found in one-month stability. 
CONCLUSION 
This project was conducted to exploit the activity of isoniazid as a 
model drug by attempting targeting drug delivery in the form of a 
liposome. After the formulation of liposomes, they were evaluated to 
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estimate their particle size analysis, entrapment efficiency, release 
study and stability testing. The F1 batch showed most promising 
results compared to other. Though, long-term stability study and a 
clinical trial is required for future development of this formulation. 
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